Fred Brown

Opinion author

Frederick (Fred) W. K. Brown is senior advisor, Pharma Partnerships & Strategy at GATC Health. Dr. Brown brings decades of executive leadership across global pharmaceutical development and commercialization. He previously served as global head of Product Lifecycle at Hoffmann-La Roche, overseeing a multibillion-dollar portfolio and multiple major product launches.

AI robotic head gazes at hand holding scales on dark blue background. Ethical decision-making, fairness, and balance in artificial intelligence concept. Low polygonal abstract vector illustration

Opinion

FDA alignment is critical to serving the rare disease community. AI can help

The FDA has introduced models intended to accelerate rare disease drug development, but recent reversals of guidance from the agency speak to a lack of clarity in its implementation. AI can help focus this process.

May 18, 2026

4 min read

Rahul Gupta